Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with ...
NervGen Pharma Corp. (“NervGen” or the “Company") (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and ...
NervGen Pharma Corp. ("NervGen" or the "Company") (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class ...
The Growing Investment Case For SilverPrecious metals, especially gold, have historically held a special place in the ...
A shortlist of software development companies can look convincing in ten minutes and fall apart in the next ten. The service ...
Google I/O 2026 starts on May 19, and while we already have a pretty good idea of what to expect, there's plenty of room for ...
This month brought two fast-moving courtroom fights over tech brand names, a major USPTO modernization announcement, and a ...
Chromolume.io synthesizes the gross weekly box office receipts of Broadway shows to create industry power rankings.
Qualcomm and MediaTek are co-development partners for an AI-first smartphone that the ChatGPT creator is planning, with mass production likely in 2028 ...
This week’s ThreatsDay covers supply chain attacks, fake help desks, wiper malware, AI prompt traps, RMM abuse, phishing kits ...
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results